James M. Beck

Reed Smith LLP

Legal Influencer

Q3 | 2018

Legal Influencers

Lexology’s Legal Influencers programme recognises firms and authors that provide excellent content within a work area and region. Find out more

  • Q3 | 2018 in Healthcare and life sciences - US


Results 1 to 5 of 869

Federal Preemption of State Attempts To Ban FDA-Approved Abortion Drugs After Dobbs

USA - June 28 2022 Given what we saw in states such as Mississippi, Oklahoma, and Idaho even before the Supreme Court's in Dobbs v. Jackson Women's Health Org., ___ S…

FDCA-Based Negligence Per Se & Informed Consent Don’t Mix

USA - June 24 2022 Summary judgment was affirmed in Vesoulis v. ReShape LifeSciences, Inc., 2022 WL 989465 (5th Cir. April 1, 2022), although the recent troubling trend…

Beware of Zombie Express Preemption Presumption Precedent

USA - June 16 2022 When we (belatedly) learned of the Supreme Court’s abolition of the so-called “presumption against preemption” in express preemption cases, that…

Keeping Alert for (In)Valid Legislation

USA - June 15 2022 An amendment to the FDCA, called the “Verifying Accurate Leading-edge IVCT Development Act” - or VALID Act (cute) for short - has been wending its…

The Medical Device Labeling Exception for “Commonly Known” Hazards

USA - June 13 2022 We’ve seen a couple of decisions recently in which defendants raised the “commonly known” hazards exception for medical device labeling, so we…